Last quarter (Q ), CytoMed Therapeutics Limited's total revenue was S$―, a decrease of ― from previous quarter. In Q, CytoMed Therapeutics Limited's net income was S$―. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21
Total Revenue	-	S$ 511.19K	-	S$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	-	S$ 511.19K	-	-
Operating Expense	-	S$ 4.38M	S$ 3.45M	S$ 1.73M
Operating Income	-	S$ -3.87M	S$ -3.45M	S$ -1.73M
Net Non Operating Interest Income Expense	-	S$ 234.44K	S$ 2.10K	S$ -114.33K
Other Income Expense	-	S$ 329.80K	S$ -458.30K	S$ -209.39K
Pretax Income	-	S$ -4.13M	S$ -5.60M	S$ -2.05M
Tax Provision	-	S$ 653.00	S$ 1.64K	S$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	S$ -25.03K	-
Net Income Common Stockholders	-	S$ -4.13M	S$ -5.60M	S$ -2.05M
Basic EPS	-	S$ -0.39	-	-
Diluted EPS	-	S$ -0.39	S$ -0.30	-
Basic Average Shares	-	S$ 10.63M	S$ 18.68M	-
Diluted Average Shares	-	S$ 10.63M	S$ 18.68M	-
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	S$ 2.00K
Total Expenses	-	S$ 4.38M	S$ 3.45M	S$ 1.73M
Net Income From Continuing And Discontinued Operation	-	S$ -4.13M	S$ -5.60M	S$ -2.05M
Normalized Income	-	S$ -3.04M	-	S$ -2.05M
Interest Expense	-	-	-	S$ 117.70K
EBIT	-	S$ -4.08M	S$ -5.60M	S$ -1.93M
EBITDA	-	S$ -3.70M	S$ -5.49M	S$ -1.60M

Currency in SGD

CytoMed Therapeutics Limited Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing